Ginsburg joins the institute from Millennium Pharmaceuticals, where he was vice president of molecular and personalized medicine. Ginsburg earned an MD and PhD from
Sigma-Aldrich announced last week that Jai Nagarkatti, president of the company's scientific research business unit, has been elected president and chief operating officer. He replaces David Harvey, who will continue as chairman of the board and chief executive officer. Three business units - scientific research, biotechnology, and fine chemicals - will now report to Nagarkatti, the company said.
Nagarkatti's 28-year career at Sigma-Aldrich has spanned R&D, manufacturing, operations, and sales and marketing, the company said. Prior to his role as president of the scientific research business unit, he was president of the fine chemicals business. Nagarkatti holds an MS in chemistry from
Jeffrey Price has accepted a faculty position at the Burnham Institute, Inside Bioassays, GenomeWeb News' sister publication, reported this week. Price joins the Burnham Institute from the
Price said that he is forming a new biotech startup company, Vala Sciences. He previously founded Q3DM, a startup that specialized in automated microscopy and was purchased by Beckman Coulter late last year. Price also served as a consultant to Beckman Coulter following the deal. He holds an MD from Loma Linda University, and a PhD from UCSD.
Sofinnova Ventures, a San Francsico-based venture firm investing in early-stage life science companies, said that Nicola Campbell has joined the firm as a life science partner.
Campbell was previously a principal with BA Venture Partners, where she focused on mid-stage investment opportunities in drug discovery and product-based companies, Sofinnova said. Prior to this, she was at Burrill & Co., a life science merchant banking firm focusing on biotechnology venture capital. She has also been employed by Genentech in business development and scientific roles. She received a PhD in molecular and cellular immunology from Mount Sinai Medical Center.